Supplement: Glycaemic Control, Hypoglycaemic Symptoms and Effectiveness of Treatment Intensification in Type 2 Diabetes Mellitus

Diabetes, Obesity and Metabolism
Volume 10, Issue s1, June 2008

Foreword

Treatment intensification in patients with type 2 diabetes
Anthony H. Barnett
pages iii–iii

Original Articles
Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta-analysis
J. Belsey G. Krishnarajah
pages 1–7

Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study
F. Álvarez Guisasola, P. Mavros, G. Nocea, E. Alemao, C. M. Alexander D. Yin
pages 8–15

Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France
P. Vexiau, P. Mavros, G. Krishnarajah, R. Lyu D. Yin
pages 16–24

Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study
F. Álvarez Guisasola, S. Tofé Povedano, G. Krishnarajah, R. Lyu, P. Mavros D. Yin
pages 25–32

Development of a diabetes treatment simulation model: with application to assessing alternative treatment intensification strategies on survival and diabetes-related complications
J. Chen, E. Alemao, D. Yin J. Cook
pages 33–42

Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy
B. Schwarz, M. Gouveia, J. Chen, G. Nocea, K. Jameson, J. Cook, G. Krishnarajah, E. Alemao, D. Yin H. Sintonen
pages 43–55